Orbimed Advisors LLC Obs Eva Sa Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$1.89 - $2.55 $2.46 Million - $3.32 Million
-1,303,000 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$2.46 - $6.15 $3.2 Million - $8.01 Million
-1,302,531 Reduced 49.99%
1,303,000 $3.23 Million
Q3 2017

Nov 14, 2017
BUY
$6.38 - $8.14 $16.6 Million - $21.2 Million
2,605,531
2,605,531 $21.2 Million

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email